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Abstract 
Context. The study of any wild animal’s home range requires the collection of 
spatiotemporal data, obtained independently of climatic conditions or time of day. This can 
be achieved by the attachment of Global Position System (GPS) data loggers, which, in large 
species, is best achieved by remote immobilisation. Feral horses (Equus caballus) usually 
occupy remote areas of Australia, however a considerable population increase has been 
observed in a close proximity to metropolitan areas of the Australian east coast, creating 
increasing conflict with human interests. 
Aim. The aim of this study was to investigate the efficacy of remote chemical immobilisation 
of feral horses with medetomidine combined with tiletamine-zolazepam to facilitate 
placement of satellite GPS collars.  
Methods. Nine feral horses were darted from the ground with 60 mg of medetomidine and 
1500 mg of tiletamine-zolazepam. The effects of medetomidine were reversed with 50-100 
mg of atipamezole 30-40 minutes post induction (IV/IM). Physiological variables monitored 
during anaesthesia were heart rate, respiratory rate, temperature and oxygen haemoglobin 
saturation (SpO2).   
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Key results.  All horses were successfully immobilised with between one and three darts (n = 
9). The mean dose of medetomidine was 0.15 ± 0.01 mg kg
-1
 (SEM) and tiletamine-
zolazepam was 3.61 ± 0.16 mg kg
-1
. Mean time from darting to lateral recumbency was 13 ± 
2.7 min, and mean recumbency time was 54 ± 13 min. Vital signs for all anaesthetised 
animals remained within normal range during anaesthesia, with the exception of one animal 
displaying a transient drop in SpO2. No mortalities were encountered. 
Key conclusions. The combination of medetomidine and tiletamine-zolazepam provided 
adequate anaesthesia in feral horses in the field for application of GPS collars.  
Implications. Although a limited number of horses were immobilised, this study shows that 
medetomidine and tiletamine-zolazepam provides effective short-term anaesthesia for feral 
horses, providing a practical and field-accessible capture technique. This method could also 
be applied to other management actions requiring safe and humane capture of feral horses. 
Additional keywords: feral horse, remote immobilisation, medetomidine, tiletamine-
zolazepam, atipamezole. 
Introduction 
To safely and humanely place GPS collars on wildlife, reliable capture methods are essential 
(Geschke and Chilvers 2009). In the case of feral horses, a reliable method of remote 
immobilisation is necessary to facilitate safe and humane capture and subsequent handling of 
the subject animal (Kaczenski 2010). 2006). For field anaesthesia to be effective, it should be 
fast, smooth, reversible, and pose minimal safety risks to the target animal and personnel 
involved in the anaesthetic regimen (Walzer et al. 2006). Remote immobilisation of wild 
equids in the field is often perceived to be difficult (e.g. Walzer and Kaczensky 2004) despite 
a large number of demonstarted techniques for wild herbivore species with similar body size 
(e.g. Jalanka and Roeken 1990; Tyler et al. 1990; McMahon and Bradshaw 2008; Boardman 
et al. in press).  
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The most commonly used agent to remotely immobilise non-domesticated equids is the 
potent opioid, etorphine hydrochloride (Matthews 1993; Walzer et al. 2006; Hampson et al. 
2010; Rosu et al. 2012). Despite its high potency and availability of an antagonist that 
enables rapid and complete reversal, etorphine is restricted for use in many countries, 
including Australia, and difficult to import (Woolnough et al. 2012; Australian Government, 
Department of Health and Aging, 2013).  
Investigations of alternatives to etorphine have led to use of combinations of α-2 adrenergic 
agonists (xylazine, detomidine, romifidine, medetomidine) with cyclohexamines (ketamine, 
tiletamine) (Barasona et al. 2013; Matthews et al. 1995; Walzer et al. 2006; Rosu et al. 
2012). In particular, the potent α-2 adrenergic agonist medetomidine, in combination with the 
cyclohexamine ketamine, has demonstrated reliable and reversible remote immobilisation of 
a diverse range of ungulate species, including forest reindeer (Rangifer tarandus fennicus; 
Jalanka 1989), ibex (Capra i. ibex; Jalanka and Roeken 1990), Przewalski’s horse (Equus 
ferus przewalskii; Matthews et al. 1995), donkeys (Equus asinus; Woolnough et al. 2012) and 
dromedary camels (Camelus dromedarius; Boardman et al. in press). The anaesthetic effects 
of medetomidine can be reversed, or antagonised, by the α-2 adrenergic antagonist 
atipamezole, with the effects of cyclohexamines dissipating over time (Woolnough et al. 
2012).  
Medetomidine is an α-2 antagonist with significant sedative and analgesic properties which 
provides muscle relaxation and allows smooth induction and recovery from anaesthesia 
(Bettschart et al. 1999; Muir and Hubbell 2009). Ketamine and the closely related tiletamine, 
cause dissociative anaesthesia characterised by catalepsy, amnesia, and analgesia (Muir et al. 
2000; Muir and Hubbell 2009). Zolazepam is a benzodiazepine-like drug with sedative and 
muscle relaxation effects (Muir et al. 2000). Tiletamine is commercially available combined 
with zolazepam (Zoletil
®
 or Telazol
®
), a benzodiazepine-like tranquiliser (Muir et al. 2000). 
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The advantage of the medetomidine and tiletamine-zolazepam combination is that it acts 
synergistically, with lower required doses, offers broad anaesthesia safety margins, well-
preserved cardiovascular function and muscle relaxation (Jalanka and Roeken 1990). These 
effects, however, sometimes result in prolonged recovery and there is no readily available 
antagonist, or reversal agent (Matthews et al. 1991; Muir et al. 2000). The solubility of the 
concentrated ketamine preparations is insufficient to allow dosing darts with a capacity 
restricted to 3ml. In contrast, the advantage of using the tiletamine-zolazepam combination 
over ketamine is its superior solubility, permitting very high drug concentrations in minimal 
volumes (Matthews 1993), which in turn permits usage of darts of smaller capacity (such as 
the Pneu-dart tracker dart of a capacity of 3.0 ml used in the present study). In addition, the 
combination improves the reliability of sedative properties of either drug alone (tiletamine or 
zolazepam) without adding extensively to further vital organ depression (Booth and 
McDonald 1988). 
The combination of medetomidine and tiletamine-zolazepam has not previously been tested 
in remote immobilisation of feral horses in field conditions. Therefore, the purpose of this 
research was to investigate the efficacy of medetomidine in combination with tiletamine-
zolazepam as a case study for remote immobilisation of nine feral horses for the placement of 
GPS collars. Anaesthetic and physiologic data was collected in order to evaluate efficiency 
and safety of this drug combination, to provide rapid and smooth induction by remote 
intramuscular injection, and be easily reversible, which will provide an effective form of 
anaesthetic for shorter field procedures performed on feral horses.  
Materials and methods 
Study area 
This study was conducted in the Tuan and Toolara State Forest (TTSF), located on South-
East Queensland in Australia (25
o53’S and 152o50’E; Figure 1) between August and 
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November 2013). The mean temperatures during the study were in a range of 20.4 - 27.0
◦
C 
(Australian Government, Bureau of Meteorology, 2013). High environmental temperatures 
need to be considered when performing general anaesthesia in the field, with regard to 
potential hyperthermia of immobilised animals (Geschke and Chilvers 2009; Berger et al. 
2010; Woolnough et al. 2012). 
 
Figure 1: Map of Australia showing Queensland, Fraser Island and the location of the Tuan 
and Toolara State Forest (TTSF) on the central east coast. 
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Animals 
Horses involved in this study were members of established breeding groups (n = 9), which 
were a part of a larger observational study.  Individual horses were selected randomly and 
included mature males (n = 7) and females (n = 2). Selected horses were healthy in 
appearance with an estimated body weight based on visual appraisal of 400-500 kg. Selected 
females were not obviously pregnant and were without dependent foals.  
Immobilisation procedure 
All horses in the study were immobilised with medetomidine hydrochloride (Bova 
Compounding, New South Wales, Australia), and toletamine-zolazepam (Zoletil; Virbac, 
Queensland, Australia), which is a soluble powder consisting of equal parts of tiletamine and 
zolazepam. All horses received the same drug dosage which was approximated for 450 kg 
animal. Medetomidine (60 mg, at concentration of 40mg/ml) was mixed with 750 mg of 
tiletamine powder, 750 mg of zolazepam powder, and 0.5 ml of saline. Following several 
attempts to solubilise the tiletamine-zolazepam powder using only medetomidine, it was 
ascertained that 0.5 ml of sterile saline facilitated the solubilisation process, as well as 
providing a balanced dart volume. Remote injection of the anaesthetic agents was facilitated 
by 3 ml C-type explosive-powered metal darts equipped with VHF transmitters (Pneu-Dart, 
Pennsylvania, USA) which enabled location of the darted animals in dense forested 
vegetation using a Yagi antenna (Sirtrack Ltd, Havelock North, New Zealand). This 
requirement limited the available dart volume to 3 ml because of the commercial availability 
of tracking darts. Darts were fitted with 3.8 cm wire twin-barbed needles (Pneu-Dart, 
Pennsylvania, USA) and were delivered using an x-calibre
®
 CO2 powered dart gun (Pneu-
Dart, Pennsylvania, USA). As transmitters added considerable weight to the dart, the 
shooting range to non-habituated to human presence horses was reduced to 40 meters. 
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Remote immobilisation was performed by a professional shooter and supervised by a 
veterinarian.  
All animals were approached on foot and were darted while standing or grazing and the 
chosen darting site was the lateral shoulder, neck or rump and the intended injection route 
was intramuscular (IM). Distance travelled by each horse was measured by a GPS (Garmin 
Oregon 550, Garmin International, Kansas, USA) and reported distances are from the last 
successful dart.  Immobilisation was deemed to be achieved when the darted animal was 
observed to be in lateral recumbency (as per Walzer et al. 2006). Once immobilised, horses 
were quietly approached from behind and sometimes repositioned to avoid rocks and 
vegetation, or to reduce visceral pressure on the diaphragm secondary to head- down-hill 
positioning. Animals were blindfolded with a blanket to reduce visual stimulation and to 
diminish potential injury to their eyes.  
Anaesthetic monitoring of physiological parameters was performed immediately after lateral 
recumbency was achieved and then every 15 minutes until the animal was standing. Heart 
rate (HR) was recorded by auscultation; respiratory rate (RR) by counting chest excursions; 
pulse strength by digital pressure of the facial artery and body temperature by a thermometer 
placed in the rectum. Mucous membrane colour (MM), capillary refill time (CRT), palpebral 
reflex response and anal tone were also evaluated. Haemoglobin saturation (SpO2) was 
measured by a battery powered c-clamp pulse oximeter (Edan, California, USA), placed on 
the tongue. Oxygen supplementation via nasal insufflations at 10 L min
-1
 was administered 
when SpO2 fell below 90%. Oxygen was delivered from a portable high pressure cylinder 
(BOC Australia Ltd, NSW, Australia) fitted with a regulator flow meter and connected to the 
horse by 3 m of 14 mm internal diameter plastic tubing. 
Body weight was calculated while the animal was anaesthetised and in lateral recumbency 
using the formula of Carroll and Huntington (1988):  
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Weight (kg) = 
𝑔𝑖𝑟𝑡ℎ2𝑥 𝑙𝑒𝑛𝑔𝑡ℎ
𝑌
 
The perpendicular distance from the dorsal midline immediately caudal to the withers and the 
ventral midline was doubled to provide the girth measurement. The distance from point of hip 
to point of shoulder was measured as being representative of body length (Milner and Hewitt 
1969), and the divisor ‘Y’ equalled to 11900 (Carroll and Huntington 1988). This calculation 
allowed approximation of drug administered per kg of horse. Age was approximated by 
dental examination (as per Baker and Easley 1999).  
Time to lateral recumbency was measured as the time from first dart placement to the time 
the horse became recumbent (as per Woolough et al. 2012). In horses darted multiple times, 
some darts bounced off or embedded in superficial tissues. In horses darted with more than 
one dart, time to lateral recumbency was measured from the successful delivery of the last 
dart to lateral recumbency. Drug absorption from these ineffective darts was assumed to be 
zero (as per Woolough et al. 2012) and they were not included for calculation of final drug 
dosage. Total recumbency time was measured from initial recumbency to standing in 
minutes.  
Immobilisation was reversed with an initial dose of 50mg of atipamezole (Illium 
Atipamezole, Troy Laboratories, NSW, Australia, concentration of 5mg/ml) intravenous (IV) 
and/or intra-muscular (IM) 30-40 minutes post induction. If the recovery was prolonged, then 
an additional dose of atipamezole equal to 25mg (IV) was given 25 and 60 minutes after the 
initial dose.  Recovery time was measured in minutes as the time from first administration of 
atipamezole to the time the horse stood and remained standing.  
Further observations were performed from a safe distance to ensure recovery was complete, 
which was expressed as sufficient muscular strength and coordination of movements to 
remain standing (Clark-Price 2013). Within 24-48 hours of recovery, all horses were 
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reassessed to see if they were of normal demeanour and that they had returned to their 
harems.  
Results are presented as mean ± SEM and range.  
Results 
Immobilisation 
Drug doses, animal details, induction, anaesthesia and recovery data for all horses are 
presented in Table 1. Tabulated drug doses were calculated retrospectively after estimation of 
body weight post darting. Five horses (animals 1 - 5) became laterally recumbent after 
administration of one dart, three horses (animals 6, 7, and 8) required two darts to become 
recumbent and one horse (animal 9) required three darts to achieve lateral recumbency. The 
mean dose for medetomidine for all nine animals was 0.15 ± 0.01 mg kg
-1
 and for tiletamine-
zolazepam was 3.61 ± 0.16 mg kg
-1
. In all horses, a stilted gait was observed within 2-3 of 
darting, followed by progressive ataxia and lateral recumbency within 13 ± 2.7 min. 
Distances travelled by horses after a successful dart varied from 60 – 813 m, and averaged at 
194 ± 79.6 SEM meters.  
Anaesthesia 
On average, all horses were laterally recumbent for 54 ± 13 minutes. All measured variables 
were within normal ranges for the duration of the anaesthesia in all horses (Table 2) with the 
exception of one horse (animal 1) displaying a transient drop in haemoglobin saturation. 
Recovery 
Following the administration of atipamezole at a mean of 37 ± 1.6 min post induction, all 
horses stood within 31 ± 13 min.  In one horse, where 75% of the calculated dose of 
atipamezole was given IM and 25% IV, totalling 100 mg, the recovery was prolonged and 
lasted 115 min. In the second horse, where 25 mg atipamezole was given IV and 25 mg IM, 
the recovery was rapid and lasted five min. Subsequently, the remaining seven horses 
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received 50 mg atipamezole IV. Amongst six horses the average recovery length was 9.3 ± 3 
min. One horse experienced a longer recovery; therefore, it additionally received 25 mg of 
atipamezole (IV) 25 minutes from the initial dose and recovered in 37 min. One horse did not 
recover from the initial dose, so subsequently it was given 25mg of atipamezole (IV) at 25 
minutes and 25 mg of atipamezole (IV) at 60 minutes from the initial dose totalling100 mg. 
The recovery length of this horse was 70 min. 
Most horses (n = 7; 77.8%) had a smooth recovery, which started with head-lifting and 
progressed to sternal recumbency, followed by less than three attempts to stand. Two (22.2%) 
horses had shorter recoveries characterised by three attempts to stand before standing. 
Despite remaining standing, all horses appeared moderately sedated, and, if not stimulated, 
moved very little for the next 3-4 hours. If stimulated to move, horses were ataxic, but the full 
control of body movements returned after two hours of standing.  
Eight individuals eventually returned to their harems. One horse re-joined his harem on the 
same day, five horses the following day; and two horses remained by themselves for more 
than two days before re-joining their harems. One horse was euthanised within 16 hours of 
recovery because of an injury sustained during anaesthetic induction. The post-mortem 
examination revealed that while the horse fell to the ground, its body weight had driven the 
dart into the chest cavity causing a pneumothorax and lung collapse. 
Discussion 
The combination of medetomidine and tiletamine-zolazepam produced adequate short-term 
immobilisation of all feral horses in field conditions. This is the first known study, to have 
used this drug combination to remotely immobilise free ranging horses. A single 3-ml dart 
was sufficient to produce immobilisation in 55.6% horses, with consistently short times to 
lateral recumbency. Depth of anaesthesia in these horses was variable but anaesthesia was 
generally short, and all measured physiological parameters were within normal ranges 
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(Coumbe 2001). The recoveries varied in time, but were smooth and resulted in no visible 
injuries to immobilised horses. Similarly, 44.4% of horses that required more than one dart to 
become recumbent exhibited short times to lateral recumbency after the administration of the 
final dart. The stability of lateral recumbency in these horses was more variable as were the 
average recovery times. The overall recumbency time produced by this combination was 
longer than for many similar studies (e.g. Woolnough et al. 2012; Boardman et al. 2014). 
In four horses, which were not immobilised with one dart, the initial dart bounced off or 
embedded in the target tissue subcutaneously. As a result, two horses in which the dart 
bounced off, showed a lack of response to the initial drug dosage, and in the other two 
instances, responses to the drugs were muted despite at least one of the subsequent darts 
embedding in the targeted animal's tissues. This procedure agitated the horses, and caused 
them to move, potentially bypassing the sedative effect. It is possible to conclude from these 
observations that where the dart did not initially lodge, or embed in the subcutaneous tissue, 
it may not have impacted with adequate force to inject a sufficient volume of drug to cause 
immobilisation, or the drug was subcutaneous and, therefore, had a slower effect (Rosu et al. 
2012). Residual drug present in darts that bounced off the animals was observed but was not 
measured in the current study. Individual variation of anaesthetic responses varies between 
animals of the same species, and differences in age, gender, body condition, physiological 
state of the animals at the time of drug delivery may potentially affect drug absorption rates 
(Geschke and Chilvers 2009; Roelle and Ransom 2009).  
Despite the differences in body size between the individual horses, it was not possible to 
constitute and deliver individual drug doses under the field conditions in which the study was 
conducted. The use of standardised total drug doses, rather than tailored individual doses, is 
reflected in the variability in drug dosages seen in Table 1. Measurement of body weight after 
immobilisation in the first four horses indicated that the drug combination dose selected was 
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more appropriate for male horses with a more uniform body weight of around 450 kg, hence 
the preponderance of males in this study. 
In the current study, all animals were darted while standing or grazing, but numerous factors 
potentially influenced dart performance. For example, thick ground vegetation made it easier 
for the shooter to approach the horses, but the vegetation impeded progress of the dart. 
Observations made by the shooter revealed that wind speed affected dart trajectory which 
deviated from the target in two instances. Sudden movement of two horses also resulted in 
darts not embedding in the target tissue correctly.  
The dose of medetomidine used in the current study was higher than the dose used in a 
previous study on use in Przewalski’s horses (0.07-0.10 mg kg-1; Matthews et al. 1995), and 
slightly higher than that used to immobilise feral donkeys (0.14 mg kg
-1
; Woolnough et al. 
2012). Other studies have shown that comparable doses of medetomidine to those used in the 
current study have been administered to large ungulates previously without lethal side effects 
(Tyler et al. 1990; Haulena et al. 2000; Woolnough et al. 2012; Boardman et al. in press).  
Heart and respiratory rates were within normal ranges, but SpO2 values showed that 
haemoglobin saturation decreased with anaesthesia and was of sufficient concern in one horse 
(11.1%) to warrant the administration of oxygen by nasal insufflation. If nasal oxygen is not 
available in the field then anaesthetic duration should be minimised by administering 
atipamezole as soon as possible to reverse medetomidine. The risk of early atipamazole use, 
however, could lead to residual effects of tiletamine and zolazepam, such as prolonged ataxia 
and distress to the animal (Muir et al. 2000). Greater dosing accuracy of medetomidine and 
tiletamine-zolazepam is also likely to reduce unwanted effects of anaesthesia, such as 
decreased haemoglobin oxygen saturation (Muir and Hubbell 2009).  
Sedative and anaesthetic agents depress thermoregulatory function and both hypo-and 
hyperthermia can be of significance depending upon the ambient temperature and the 
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duration of anaesthesia in the field (Delvaux et al. 1999). The metabolic effects associated 
with the escape response in wild animals may significantly raise the core and therefore rectal 
temperature of captured animals (Woolnough et al. 2012). Despite moderately high ambient 
humidity and temperature during the period over which the darting study occurred, the rectal 
temperature of immobilised horses remained within the published normal range (Coumbe 
2001).  
The use of reversal agents is desirable in feral and wild animal field anaesthesia, as it 
diminishes the risks associated with anaesthetic procedures (Walzer et al. 2006). In wild 
animal capture studies involving α-2 adrenergic sedatives, atipamezole has been successfully 
employed to accelerate animal recovery and reduce the costs of anaesthesia monitoring 
(Matthews et al. 1995; Ramseyer et al. 1998; Hubbell and Muir 2006). However, timing of 
atipamezole administration is important irrespective of whether an α-2-antagonist is the only 
drug administered or if it is combined with other sedatives or anaesthetics. In field 
anaesthesia, atipamezole administered subcutaneously (SC) and IV at doses of 0.17-0.23 mg 
kg
-1
 30 minutes after remote delivery of medetomidine and ketamine did not result in 
complete reversal and was associated with variable recovery times in Przewalski’s horses, 
which was believed to be due to persisting effects of ketamine (Matthews et al. 1995). Larger 
doses of atipamezole administered 15 minutes after medetomidine and ketamine, 
significantly shortened recovery time but did not eliminate residual effects of ketamine in 
feral donkeys (Woolnough et al. 2012).  
There is no readily available antagonist for tiletamine-zolazepam (Muir and Hubbell 2009). 
Administration of atipamezole in this study was deliberately delayed to 37 (± 4 SEM) min 
post induction to ensure that when the effect of medetomidine was neutralised, the residual 
effects of tiletamine-zolazepam were reduced. Earlier administration of atipamezole would 
have meant that the level of α -agonist reversal would have been influenced by the persistent 
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of the tiletamine-zolazepam sedation and arousal would have been diminished. As a result, 
rapid and smooth recoveries and return to standing was obtained in 77.8% horses. The 
approach was similar to that of Woolnough et al. (2012), where α-2 adrenergic antagonist 
administration to 30-40 minutes post induction, avoiding residual ketamine effects and 
enhancing the smoothness of recoveries.   
Anaesthetic time of wild equids should be reduced to a minimum (Walzer et al. 2006; 
Woolnough et al. 2012) but our study reported an extended mean time in lateral recumbency 
of 54 (± 13 SEM) min. For example, the first horse received 75% of the calculated dose of 
atipamezole by IM injection. Time to standing in this horse was slow (115 min), which could 
have been influenced by the route of administration. Subsequent horses were given 50% (n = 
1) or 100% (n = 7) of the calculated atipamezole dose IV, which considerably shortened their 
recumbency and recovery times (Table 1). When atipamezole was administered 
intravenously, the recovery was considerably more rapid, was associated with a moderate 
degree of ataxia, and in general involved a lower dosage. Extended recovery time of the last 
horse could have been a result of a larger dose of anaesthetic agents received by three 
consecutive darts. The amount of drug injected from darts which dislodged and/or bounced 
off was unknown and was assumed to be nil when calculating dose rates, however some 
absorption could have occurred. To reduce recumbency times, further research could 
investigate the combination of the shorter-acting but less soluble ketamine with 
medetomidine (as per Mathews et al. 1995) in contexts that permit larger dart sizes 
(helicopter darting, trapped animals). Investigation of adding the enzyme hyaluronidase (as 
per Cattet and Obbard 2010) may also be warranted to reduce induction times.  
Legislative requirements surrounding the use of the potent opiate etorphine are prohibitive in 
Australia (Australian Government, Department of Health and Aging, 2013). The occupational 
hazards posed by etorphine make it very difficult to acquire licenses to use the drug for 
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operational immobilisation programs (Woolnough et al. 2012). Less potent opiates, such as 
butorphanol, are often added to the medetomidine–ketamine combination (e.g. Miller et al. 
2009; Boardman et al. in press). However, opiates are Schedule 8 drugs in Australia 
(Australian Government Department of Health and Aging 2013), reducing their accessibility 
for field techniques (see Woolnough et al. 2012). In addition, the high cost of butorphanol, 
and its antagonist, naltrexone, render such regimes relatively expensive when compared with 
methods not including an opiate. For these reasons, an opiate was not included in the 
immobilisation regime in the current study. In contrast, the use of medetomidine and 
tiletamine-zolazepam offers an accessible and practical option for operational control 
programs of feral animals in the field.  
Conclusion 
The combination of 60 mg of metedomidine and 1500 mg of tiletamine-zolazepam allowed 
safe, partially reversible and cost effective remote immobilisation of nine feral horses in their 
natural environment of the Tuan and Toolara State Forest. This approach was practical for the 
study operators as it only involved the use of three drug preparations and did not require the 
use of restricted substances. The ability to safely immobilise feral horses for the attachment 
of telemetry equipment or collection of health and physiological data is important for the 
understanding of the biology of the species. The practicality of capture techniques is an 
important consideration for managers to facilitate live removal or euthanasia of feral horses 
during management operations where lethal methods are not acceptable (Chapple 2005; 
Nimmo and Miller 2007). The ability to capture feral horses in the TTSF and similar land 
tenures by chemical immobilisation will advance current non-lethal management options 
which are primarily based on mustering and trapping (Berman 2013). This technique will be 
of particular importance in the forestry areas located near major public roads, where 
mustering of animals may increase risk of collisions with vehicles. Future research should be 
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aimed at optimising dose rates and delivery mechanisms for medetomidine and tiletamine-
zolazepam, comparing with medetomidine-ketamine, and providing additional information on 
the safety, efficacy, and physiological responses of horses immobilised with this drug 
combination.  
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Table 1. 
Summary data detailing animal characteristics, drug dosages based on calculated horse 
weight, number of delivered darts; and anaesthetic time effects in nine feral horses remotely 
immobilised with medetomidine and tiletamine-zolazepam in the Tuan and Toolara State 
Forest; LR – lateral recumbency; SEM – standard error of the mean. 
1 
 
ID Sex 
Age 
(years) 
Body 
weight (kg) 
Medetomidine 
(mg kg-1) 
Tiletamine-
Zolazepam   
(mg kg-1) 
Atipamezole 
(mg kg-1) 
No. of 
darts 
Time to LR       
(min) 
LR time  
(min) 
Recovery  
time  (min) 
1 F 6 434 0.15 3.44 0.23 1 6 139 115 
2 F 15 320 0.20 4.69 0.15 1 5 46 19 
3 M 11 474 0.13 3.16 0.10 1 10 28 5 
4 M 5 430 0.14 3.49 0.12 1 28 26 7 
5 M 7 414 0.14 3.60 0.18 1 9 62 37 
6 M 6 481 0.17 3.12 0.10 2 25  18 5 
7 M 6 432 0.15 3.47 0.12 2 15  46 18 
8 M 4 387 0.16 3.88 0.13 2 8  29 2 
9 M 5 446 0.14 3.63  0.22 3 14  92 70 
Mean 
± SEM 
 7.2 
1.18 
424 
16.12 
0.15 
0.01 
3.61 
0.16 
0.15 
0.02 
2 
0.24 
13 
2.73 
54 
13.04 
31 
12.74 
 
1 
 
Table 2.   
Measured parameters of remotely immobilised feral horses (n = 9) with medetomidine and 
tiletamine-zolazepam in the Tuan and Toolara State Forest; HR – heart rate; RR – respiratory 
rate; Temp – body temperature; SpO2- haemoglobin saturation, and CRT-capillary refill time.  
Parameter Mean ± SEM Range 
HR (min) 43 ± 1.4 35 - 48 
RR (min) 19 ± 1.6 14 - 30 
Temp (
O
C) 38.4 ± 0.2 38.2 - 38.7 
SpO2 (%) 87 ± 2.2 79 - 94 
CRT (sec) 2.3 ± 0.2 2 - 3 
 
